Invention Grant
- Patent Title: Virulence attenuated bacteria based protein delivery
-
Application No.: US16471264Application Date: 2017-12-20
-
Publication No.: US11518789B2Publication Date: 2022-12-06
- Inventor: Simon Ittig , Marlise Amstutz , Christoph Kasper
- Applicant: UNIVERSITÄT BASEL
- Applicant Address: CH Basel
- Assignee: UNIVERSITÄT BASEL
- Current Assignee: UNIVERSITÄT BASEL
- Current Assignee Address: CH Basel
- Agency: Bozicevic, Field & Francis LLP
- Agent Shweta Chandra
- Priority: EP16205439 20161220
- International Application: PCT/EP2017/083853 WO 20171220
- International Announcement: WO2018/115140 WO 20180628
- Main IPC: A61K39/02
- IPC: A61K39/02 ; A61K45/00 ; A61K47/00 ; A01N63/00 ; A61K48/00 ; C07K14/24 ; A61P35/00 ; C12N1/20 ; C12N1/36 ; C12N15/74 ; A61K38/00
Abstract:
The present invention relates to recombinant virulence attenuated Gram-negative bacterial strains and its use in a method of treating cancer in a subject.
Information query
